Trials / Sponsors / Oana Danciu
Oana Danciu
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 2 | 2022-09-13 |